Partial Reversal of Cachexia by β-adrenergic Receptor Blocker Therapy in Patients with Chronic Heart Failure

Journal of Cardiac Failure

Volumn 9, Issue 6, 2003, Pages 464-468

  Hryniewicz, Katarzyna ^a,b   Androne, Ana Silvia ^a,b   Hudaihed, Alhakam ^a,b   Katz, Stuart D ^a,b  

^a Yale University College of Medicine ^*

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical pharmacology; Norepinephrine; Sympathetic nervous system

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; INSULIN; LEPTIN; METOPROLOL SUCCINATE; NORADRENALIN;

ADRENERGIC SYSTEM; ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BODY WEIGHT; CACHEXIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HUMAN; INSULIN BLOOD LEVEL; MALE; NORADRENALIN BLOOD LEVEL; PATHOGENESIS; PRIORITY JOURNAL; WEIGHT GAIN;

EID: 0347595456     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-9164(03)00582-7     Document Type: Article

References (30)

1. Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet 1997;349:1050-3.
2. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002;85:51-66.
3. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
4. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-34.
5. Cleland JG, Clark AL. Leptin and cardiac cachexia: marker or mediator? Eur Heart J 1998;19:1421-2.
6. Morrison WL, Edwards RH. Cardiac cachexia. BMJ 1991;302:301-2.
7. Murdoch DR, Rooney E, Dargie HJ, Shapiro D, Morton JJ, McMurray JJ. Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure. Heart 1999;82:352-6.
8. Pittman JG, Cohen P. The pathogenesis of cardiac cachexia. N Engl J Med 1964;271:403-9.
9. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:2001-7.
10. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:1349-55.
11. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344:1651-8.
12. Herndon DN, Hart DW, Wolf SE, Chinkes DL, Wolfe RR. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001;345:1223-9.
13. Sharma AM, Pischon T, Hardt S, Kunz I, Luft FC. Hypothesis: Beta-adrenergic receptor blockers and weight gain: a systematic analysis. Hypertension 2001;37:250-4.
14. Conraads VM, Bosmans JM, Vrints CJ. Chronic heart failure: an example of a systemic chronic inflammatory disease resulting in cachexia. Int J Cardiol 2002;85:33-49.
15. Brink M, Anwar A, Delafontaine P. Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia. Int J Cardiol 2002;85:111-21. discussion 121-4.
16. Donahoo WT, Jensen DR, Yost TJ, Eckel RH. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion. J Clin Endocrinol Metab 1997;82:4139-43.
17. Podbregar M, Voga G. Effect of selective and nonselective beta-blockers on resting energy production rate and total body substrate utilization in chronic heart failure. J Card Fail 2002;8:369-78.
18. Coats AJ, Anker SD, Roecker EB, Schultz MK, Staiger C, Amann-Zalan I, et al. Prevention and reversal of cardiac cachexia in patients with severe heart failure by carvedilol: results of the COPERNICUS study (abstract). American Heart Association 2001 Scientific Sessions. Available from: http://aha.agora.com/abstractviewer.
19. Anker SD, Lechat P, Dargie HJ. Prevention and reversal of cachexia in patients with chronic heart failure by bisoprolol: results from the CIBIS-II study (abstract). American College of Cardiology 2003 Scientific Sessions. Available from: http://www.abstractsonline.com/viewer/searchAdvancedResults.asp.
20. Rosenbaum M, Leibel RL. The role of leptin in human physiology. N Engl J Med 1999;341:913-5.
21. Berry C, Clark AL. Catabolism in chronic heart failure. Eur Heart J 2000;21:521-32.
22. Toth MJ, Gottlieb SS, Fisher ML, Ryan AS, Nicklas BJ, Poehlman ET. Plasma leptin concentrations and energy expenditure in heart failure patients. Metabolism 1997;46:450-3.
23. Christian Schulze P, Kratzsch J, Linke A, Schoene N, Adams V, Gielen S, et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003;5:33-40.
24. Leyva F, Anker SD, Egerer K, Stevenson JC, Kox WJ, Coats AJ. Hypedeptinaemia in chronic heart failure. Relationships with insulin. Eur Heart J 1998;19:1547-51.
25. Filippatos GS, Tsilias K, Venetsanou K, Karambinos E, Manolatos D, Kranidis A, et al. Leptin serum levels in cachectic heart failure patients. Relationship with tumor necrosis factor-alpha system. Int J Cardiol 2000;76:117-22.
26. Witte KK, Clark AL. Nutritional abnormalities contributing to cachexia in chronic illness. Int J Cardiol 2002;85:23-31.
27. Freeman LM, Roubenoff R. The nutrition implications of cardiac cachexia. Nutr Rev 1994;52:340-7.
28. Poehlman ET, Scheffers J, Gottlieb SS, Fisher ML, Vaitekevicius P. Increased resting metabolic rate in patients with congestive heart failure. Ann Intern Med 1994;121:860-2.
29. Davos CH, Doehner W, Rauchhaus M, Cicoira M, Francis DP, Coats AJ, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003;9:29-35.
30. Lissin LW, Gauri AJ, Froelicher VF, Ghayoumi A, Myers J, Giacommini J. The prognostic value of body mass index and standard exercise testing in male veterans with congestive heart failure. J Card Fail 2002;8:206-15.